EDAP

Edap TMS SA

Price Chart

Latest Quote

$4.32

+0.00 (+0.00%)

Current Price

Previous Close	$4.32
Open	$4.46
Day High	$4.32
Day Low	$4.32
Volume	56,370

Fetched: 2026-06-19T22:16:48

Stock Information

Shares Outstanding	37.48M
Total Debt	$27.79M
Cash Equivalents	$15.01M
Revenue	$74.07M
Net Income	$-30.89M
Sector	Healthcare
Industry	Medical Distribution
Market Cap	$161.92M
EPS (TTM)	$-0.82
Exchange	NGM

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$191.94M
Sales	$74.07M
Income	$-30.89M
Book/sh	$0.52
Cash/sh	$0.40
Employees	289

Financial Ratios

Quick Ratio	0.94
Current Ratio	1.34
Debt/Eq	275.14

Returns & Margins

ROA	-20.31%
ROE	-123.96%
Gross Margin	43.41%
Operating Margin	-41.35%
Profit Margin	-41.70%

Ownership

Insider Ownership	6.13%
Institutional Ownership	38.87%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	-7.32
P/S	2.19
P/B	8.34

Analyst Data

Recommendation	none
Target Price	$5.83

Technical Indicators

SMA20	$4.46
SMA50	$3.91
SMA200	$3.31
RSI	64.97
ATR	0.2610

Shares Float	28.06M
Short Float	0.20%
Short Ratio	1.54
Volatility	-0.10
Rel Volume	0.79

Performance History

Week	+4.61%
Month	+14.66%
Quarter	+21.68%
6 Months	+102.98%
YTD	+40.29%
Year	+166.48%
3 Years	-49.92%
5 Years	-30.97%
10 Years	+48.60%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-12	$4.77	31,076
2026-06-11	$4.70	28,667
2026-06-10	$4.66	37,637
2026-06-09	$4.52	81,069
2026-06-08	$4.60	25,670
2026-06-05	$4.56	32,265
2026-06-04	$4.62	35,291
2026-06-03	$4.58	57,438
2026-06-02	$4.65	29,427
2026-06-01	$4.78	71,205
2026-05-29	$4.32	55,872
2026-05-28	$4.20	15,512
2026-05-27	$4.10	59,473
2026-05-26	$4.31	36,774
2026-05-22	$4.30	28,204
2026-05-21	$4.33	26,690
2026-05-20	$4.25	37,050
2026-05-19	$4.32	29,084

About Edap TMS SA

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.

📰 Latest News

EDAP (EDAP) Q4 2025 Earnings Call Transcript

Motley Fool • 2026-06-01T20:53:52Z

Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion

MarketBeat • 2026-06-01T19:04:33Z

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week

MT Newswires • 2026-05-29T15:11:57Z

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires • 2026-05-28T15:14:11Z

European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading

MT Newswires • 2026-05-21T15:05:36Z

European Equities Traded in US as ADRs Rise in Wednesday Trading

MT Newswires • 2026-05-20T15:03:01Z

European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading

MT Newswires • 2026-05-19T15:27:05Z

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading

MT Newswires • 2026-05-13T15:12:40Z

Edap Tms Q1 Earnings Call Highlights

MarketBeat • 2026-05-07T19:47:52Z

European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading

MT Newswires • 2026-05-07T15:10:22Z

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$40,526,000	$40,651,000	$39,807,660	$33,153,171
Cost Of Revenue	$40,526,000	$40,651,000	$39,807,660	$33,153,171
Total Revenue	$70,527,000	$69,396,000	$66,791,577	$59,098,757
Operating Revenue	$70,527,000	$69,396,000	$66,791,577	$59,098,757
Expenses
Interest Expense	$789,000	$256,000	$256,453	$180,163
Total Expenses	$95,222,000	$91,620,000	$88,691,759	$63,663,954
Other Income Expense	$-3,577,000	$1,348,000	$-1,988,614	$2,064,365
Net Non Operating Interest Income Expense	$-537,000	$605,000	$1,192,726	$253,086
Interest Expense Non Operating	$789,000	$256,000	$256,453	$180,163
Operating Expense	$54,696,000	$50,969,000	$48,884,099	$30,510,783
Selling And Marketing Expense	$27,315,000	$27,363,000	$25,010,778	$17,564,800
General And Administrative Expense	$17,720,000	$15,243,000	$16,176,422	$7,669,787
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-29,246,000	$-20,584,000	$-23,410,159	$-3,145,342
Net Interest Income	$-537,000	$605,000	$1,192,726	$253,086
Interest Income	$252,000	$861,000	$1,449,179	$433,249
Normalized Income	$-26,420,170	$-21,648,920	$-21,839,153	$-4,776,191
Net Income From Continuing And Discontinued Operation	$-29,246,000	$-20,584,000	$-23,410,159	$-3,145,342
Total Operating Income As Reported	$-24,694,000	$-22,225,000	$-21,901,288	$-4,565,196
Net Income Common Stockholders	$-29,246,000	$-20,584,000	$-23,410,159	$-3,145,342
Net Income	$-29,246,000	$-20,584,000	$-23,410,159	$-3,145,342
Net Income Including Noncontrolling Interests	$-29,246,000	$-20,584,000	$-23,409,053	$-3,145,342
Net Income Continuous Operations	$-29,246,000	$-20,584,000	$-23,409,053	$-3,145,342
Pretax Income	$-28,808,000	$-20,271,000	$-22,697,176	$-2,247,745
Interest Income Non Operating	$252,000	$861,000	$1,449,179	$433,249
Operating Income	$-24,695,000	$-22,225,000	$-21,900,182	$-4,566,269
Gross Profit	$30,001,000	$28,744,000	$26,983,916	$25,944,514
Special Income Charges	-	-	$0	$0
Per Share
Diluted EPS	$-0.78	$-0.53	$-0.63	$-0.10
Basic EPS	$-0.78	$-0.53	$-0.63	$-0.10
Other
Tax Effect Of Unusual Items	$-751,170	$283,080	$-417,609	$433,517
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-21,035,000	$-18,586,000	$-18,337,479	$-2,410,750
Total Unusual Items	$-3,577,000	$1,348,000	$-1,988,614	$2,064,365
Total Unusual Items Excluding Goodwill	$-3,577,000	$1,348,000	$-1,988,614	$2,064,365
Reconciled Depreciation	$3,407,000	$2,777,000	$2,114,630	$1,721,198
EBITDA (Bullshit earnings)	$-24,612,000	$-17,238,000	$-20,326,093	$-346,384
EBIT	$-28,019,000	$-20,015,000	$-22,440,723	$-2,067,582
Diluted Average Shares	$37,442,155	$37,286,446	$36,996,722	$34,392,598
Basic Average Shares	$37,442,155	$37,286,446	$36,996,722	$34,392,598
Diluted NI Availto Com Stockholders	$-29,246,000	$-20,584,000	$-23,410,159	$-3,145,342
Tax Provision	$438,000	$313,000	$711,878	$897,597
Gain On Sale Of Security	$-3,577,000	$1,348,000	$-1,988,614	$2,064,365
Research And Development	$9,661,000	$8,363,000	$7,696,899	$5,276,196
Selling General And Administration	$45,035,000	$42,606,000	$41,187,199	$25,234,587
Other Gand A	$17,720,000	$15,243,000	$16,176,422	$7,669,787
Other Special Charges	-	-	-	-

Fetched: 2026-06-01

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$14,782,000	$38,853,000	$59,059,305	$73,452,798
Total Assets	$78,997,000	$89,407,000	$101,197,148	$108,444,058
Total Non Current Assets	$21,323,000	$16,300,000	$14,444,260	$11,373,849
Other Non Current Assets	$2,059,000	$1,581,000	$719,615	$703,493
Non Current Deferred Assets	$1,094,000	$865,000	$805,837	$889,018
Non Current Deferred Taxes Assets	$1,094,000	$865,000	$805,837	$889,018
Non Current Accounts Receivable	$546,000	-	-	-
Goodwill And Other Intangible Assets	$4,631,000	$3,632,000	$3,863,373	$3,363,039
Other Intangible Assets	$1,797,000	$1,127,000	$1,197,148	$776,416
Current Assets	$57,164,000	$72,591,000	$86,751,782	$97,071,282
Other Current Assets	$-1,000	$-3,000	-	-
Prepaid Assets	$1,299,000	$1,307,000	$728,459	$707,782
Inventory	$12,830,000	$19,213,000	$16,704,803	$12,632,843
Receivables	$22,584,000	$21,076,000	$21,265,683	$16,023,764
Other Receivables	$419,000	$1,368,000	$117,172	$49,330
Taxes Receivable	$879,000	$385,000	$1,408,279	$1,581,786
Accounts Receivable	$21,286,000	$19,392,000	$18,997,402	$13,903,634
Cash Cash Equivalents And Short Term Investments	$20,452,000	$30,995,000	$48,052,838	$67,706,892
Cash And Cash Equivalents	$20,452,000	$30,995,000	$48,052,838	$67,706,892
Receivables Adjustments Allowances	-	$-387,000	$-247,610	$-172,656
Notes Receivable	-	$318,000	$990,438	$661,669
Non Current Prepaid Assets	-	-	-	-
Debt
Net Debt	$3,557,000	-	-	-
Total Debt	$27,684,000	$14,461,000	$9,311,889	$10,061,234
Long Term Debt And Capital Lease Obligation	$18,333,000	$4,260,000	$3,661,084	$5,158,232
Long Term Debt	$15,903,000	$2,246,000	$2,207,484	$3,846,690
Current Debt And Capital Lease Obligation	$9,351,000	$10,201,000	$5,650,804	$4,903,002
Current Debt	$8,106,000	$8,988,000	$4,442,602	$3,696,554
Other Current Borrowings	$8,106,000	$8,988,000	$4,442,602	$3,696,554
Liabilities
Total Liabilities Net Minority Interest	$59,584,000	$46,922,000	$38,274,471	$31,628,221
Total Non Current Liabilities Net Minority Interest	$22,443,000	$7,642,000	$7,769,856	$8,348,615
Other Non Current Liabilities	$-2,000	$-1,000	$-1,105	$1,072
Non Current Deferred Liabilities	$1,412,000	$825,000	$1,222,572	$779,633
Current Liabilities	$37,141,000	$39,280,000	$30,504,615	$23,279,606
Current Deferred Liabilities	$7,098,000	$6,899,000	$4,475,764	$4,343,210
Payables And Accrued Expenses	$17,365,000	$18,830,000	$17,553,750	$11,516,477
Payables	$11,976,000	$13,093,000	$12,572,818	$7,363,082
Other Payable	$62,000	$56,000	$67,429	$7,507
Total Tax Payable	$193,000	$-8,000	$85,116	$234,855
Income Tax Payable	$193,000	$-8,000	$85,116	$234,855
Accounts Payable	$11,721,000	$13,045,000	$12,420,273	$7,120,720
Other Current Liabilities	-	$-1,000	-	$-1,072
Equity
Common Stock Equity	$19,413,000	$42,485,000	$62,922,677	$76,815,837
Total Equity Gross Minority Interest	$19,413,000	$42,485,000	$62,922,677	$76,815,837
Stockholders Equity	$19,413,000	$42,485,000	$62,922,677	$76,815,837
Gains Losses Not Affecting Retained Earnings	$-8,337,000	$-11,952,000	$-4,959,929	$-4,106,210
Retained Earnings	$-128,616,000	$-99,370,000	$-70,247,057	$-45,439,629
Other
Treasury Shares Number	$269,533	$269,533	$269,533	$286,806
Ordinary Shares Number	$37,481,986	$37,392,086	$37,103,779	$36,910,925
Share Issued	$37,751,519	$37,661,619	$37,373,312	$37,197,731
Tangible Book Value	$14,782,000	$38,853,000	$59,059,305	$73,452,798
Invested Capital	$43,422,000	$53,719,000	$69,572,763	$84,359,082
Working Capital	$20,023,000	$33,311,000	$56,247,167	$73,791,676
Capital Lease Obligations	$3,675,000	$3,227,000	$2,661,803	$2,517,989
Total Capitalization	$35,316,000	$44,731,000	$65,130,161	$80,662,527
Treasury Stock	$1,019,000	$1,019,000	$884,320	$961,941
Additional Paid In Capital	$151,314,000	$148,768,000	$133,651,688	$122,201,847
Capital Stock	$6,071,000	$6,058,000	$5,362,295	$5,121,771
Common Stock	$6,071,000	$6,058,000	$5,362,295	$5,121,771
Employee Benefits	$2,320,000	$2,438,000	$2,714,862	$2,234,877
Non Current Deferred Revenue	$966,000	$372,000	$710,772	$283,113
Long Term Capital Lease Obligation	$2,430,000	$2,014,000	$1,453,601	$1,311,542
Long Term Provisions	$380,000	$120,000	$172,442	$174,801
Current Deferred Revenue	$7,098,000	$6,899,000	$4,475,764	$4,343,210
Current Capital Lease Obligation	$1,245,000	$1,213,000	$1,208,202	$1,206,447
Pensionand Other Post Retirement Benefit Plans Current	$3,327,000	$3,351,000	$2,824,297	$2,517,989
Current Accrued Expenses	$5,389,000	$5,737,000	$4,980,932	$4,153,396
Goodwill	$2,834,000	$2,505,000	$2,666,225	$2,586,623
Net PPE	$12,993,000	$10,222,000	$9,055,436	$6,418,299
Accumulated Depreciation	$-13,973,000	$-10,918,000	$-11,486,210	$-10,433,356
Gross PPE	$26,966,000	$21,140,000	$20,541,646	$16,851,655
Other Properties	$19,228,000	$14,165,000	$13,430,609	$10,541,668
Machinery Furniture Equipment	$7,738,000	$6,975,000	$7,111,037	$6,309,987
Inventories Adjustments Allowances	$-1,484,000	$-2,134,000	$-1,396,120	$-1,353,366
Other Inventories	$-1,000	-	-	-
Finished Goods	$3,559,000	$5,938,000	$7,616,205	$5,593,626
Work In Process	$1,517,000	$1,059,000	$565,965	$303,489
Raw Materials	$9,239,000	$14,350,000	$9,918,753	$8,089,095
Non Current Pension And Other Postretirement Benefit Plans	-	$2,178,000	$2,477,201	$2,104,044
Non Current Accrued Expenses	-	-	-	-

Fetched: 2026-06-01

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-22,168,000	$-19,141,000	$-20,973,857	$-5,730,893
Operating Activities
Operating Cash Flow	$-16,409,000	$-14,703,000	$-16,225,059	$-3,242,930
Cash Flow From Continuing Operating Activities	$-16,409,000	$-14,702,000	$-16,226,165	$-3,242,930
Operating Gains Losses	$3,394,000	$558,000	$1,105	$285,258
Investing Activities
Capital Expenditure	$-5,759,000	$-4,438,000	$-4,748,798	$-2,487,962
Investing Cash Flow	$-5,715,000	$-4,459,000	$-4,801,857	$-2,550,161
Cash Flow From Continuing Investing Activities	$-5,716,000	$-4,459,000	$-4,802,962	$-2,550,161
Net Other Investing Changes	$44,000	$-21,000	$-54,165	$-62,199
Capital Expenditure Reported	$-3,716,000	$-2,766,000	$-2,855,248	$-1,683,664
Financing Activities
Financing Cash Flow	$8,610,000	$5,016,000	$-1,007,019	$23,314,995
Cash Flow From Continuing Financing Activities	$8,610,000	$5,017,000	$-1,007,019	$23,317,140
Issuance Of Capital Stock	-	$0	$0	$23,549,850
Net Other Financing Charges	-	$-1,000	-	$-2,145
Net Common Stock Issuance	-	$0	$0	$23,549,850
Common Stock Issuance	-	$0	$0	$23,549,850
Other
Repayment Of Debt	$-2,923,000	$-1,928,000	$-2,020,671	$-1,236,474
Issuance Of Debt	$12,416,000	$2,798,000	$0	$306,706
End Cash Position	$20,452,000	$30,995,000	$48,052,838	$67,706,892
Beginning Cash Position	$30,995,000	$48,034,000	$69,790,527	$50,598,934
Effect Of Exchange Rate Changes	$2,972,000	$-2,894,000	$296,247	$-416,090
Changes In Cash	$-13,515,000	$-14,145,000	$-22,033,936	$17,524,049
Proceeds From Stock Option Exercised	$0	$125,000	$288,509	$737,810
Net Issuance Payments Of Debt	$8,610,000	$4,892,000	$-1,295,529	$-970,520
Net Short Term Debt Issuance	$-883,000	$4,022,000	$725,142	$-40,751
Net Long Term Debt Issuance	$9,493,000	$870,000	$-2,020,671	$-929,769
Long Term Debt Payments	$-2,923,000	$-1,928,000	$-2,020,671	$-1,236,474
Long Term Debt Issuance	$12,416,000	$2,798,000	$0	$306,706
Net Investment Purchase And Sale	$0	$0	$1,105	$0
Sale Of Investment	$0	$0	$1,105	$0
Net Intangibles Purchase And Sale	$-832,000	$-249,000	$-590,284	$-146,918
Purchase Of Intangibles	$-832,000	$-249,000	$-590,284	$-146,918
Net PPE Purchase And Sale	$-1,211,000	$-1,423,000	$-1,303,266	$-657,380
Purchase Of PPE	$-1,211,000	$-1,423,000	$-1,303,266	$-657,380
Change In Working Capital	$2,928,000	$-2,123,000	$-3,208,976	$-4,628,468
Change In Other Current Assets	$72,000	$-620,000	$-13,265	$-87,937
Change In Payables And Accrued Expense	$-3,426,000	$3,021,000	$6,887,747	$2,382,867
Change In Accrued Expense	$-462,000	$1,683,000	$1,050,130	$1,157,117
Change In Payable	$-2,964,000	$1,338,000	$5,837,617	$1,225,750
Change In Inventory	$6,849,000	$-4,374,000	$-4,655,944	$-4,806,486
Change In Receivables	$-567,000	$-150,000	$-5,427,513	$-2,116,913
Stock Based Compensation	$2,560,000	$3,554,000	$7,588,570	$2,255,252
Provisionand Write Offof Assets	$779,000	$1,221,000	$642,237	$217,697
Deferred Tax	$-231,000	$-105,000	$46,427	$51,475
Deferred Income Tax	$-231,000	$-105,000	$46,427	$51,475
Depreciation Amortization Depletion	$3,407,000	$2,777,000	$2,114,630	$1,721,198
Depreciation And Amortization	$3,407,000	$2,777,000	$2,114,630	$1,721,198
Gain Loss On Investment Securities	$2,865,000	-	-	-
Net Income From Continuing Operations	$-29,246,000	$-20,584,000	$-23,410,159	$-3,145,342
Other Non Cash Items	-	$-1,000	$1,105	$4,225,000
Sale Of PPE	-	-	$0	$0
Short Term Debt Payments	-	-	-	-
Purchase Of Investment	-	-	-	-

Fetched: 2026-06-01